Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten

7680613170036 CH-61317 Filmtabletten
Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten
Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
06/08/2026
Summary of Product Characteristics
Français
06/08/2026
Summary of Product Characteristics
Italien
06/08/2026
Patient information leaflet
Allemand
05/08/2026
Patient information leaflet
Français
05/08/2026
Patient information leaflet
Italien
05/08/2026

Detailed composition

Substance Quantity Type Category
acidum ibandronicum
150.0 MG Substance Wirkstoff (Principe actif)
natrii ibandronas monohydricus
- Substance WIZUS
cellulosum microcristallinum
- Substance HNIDK
povidonum
- Substance HNIDK
crospovidonum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
acidum stearicum
- Substance HNIDK
E 171
- Substance FNIDK
hypromellosum
- Substance HNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
polysorbatum 80
- Substance HNIDK
natrium
10.8 MG Substance HBESI

Reimbursement information

Public price
CHF 32.30
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2012

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
61317
Drug name
Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten
Galenic form
FILM
ATC Code
M05BA06
Authorization status
Z
Dispensing category
B
First authorization
24/02/2011
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Package details

Description (FR)
IBANDRONAT Mepha 150 mg comprimés mensuels
Description (DE)
IBANDRONAT Mepha 150 mg Monatstabletten
Market launch
24/02/2011
Narcotic (BTM)
No

Original drug

Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680574240014
CHF 210.75
View original

Other package sizes (3)

None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
IBANDRONAT Mepha 150 mg comprimés mensuels 3 pce
3 TABL
GTIN: 7680613170043
View
Buy us a coffee Explore the data